PURE Bioscience
El Cajon
About PURE Bioscience
PURE Bioscience develops and markets technology-based bioscience products that provide non-toxic solutions to numerous global health challenges. The company is focused on developing and commercializing our proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. They also manufacture and sell SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products. Its proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. It was founded in El Cajon, California by Michael L. Krall in 1992.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.6M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2018)
- Ticker: otcqb:PURE
- Website: purebio.com
- Phone: (619)-596-8600
Industries & Categories
Biotechnology, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/pure-bioscience-187019 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.